Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
Enrique
Ernesto
E
Malek
Tamim
T
Castelló
José V
JV
de Mateo
José A
JA
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced / Q000276:immunology; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D016190:Carboplatin / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D003429:Cross Reactions / Q000276:immunology; D004342:Drug Hypersensitivity / Q000276:immunology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D017671:Platinum Compounds / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D012882:Skin Tests
D000970:Antineoplastic Agents; D017671:Platinum Compounds; D016190:Carboplatin; D002945:Cisplatin